REACH2: Implementation Research on Bi-Annual Mass Distribution of Azithromycin to Children 1-11 Months in Côte d'Ivoire
Status:
Recruiting
Trial end date:
2024-02-28
Target enrollment:
Participant gender:
Summary
REACH2 is a three-year implementation research study designed to examine the implementation
through a mass drug administration platform of bi-annual single-dose azithromycin to reduce
child mortality among children ages 1 to 11 months who reside in high child mortality
settings.
Phase:
N/A
Details
Lead Sponsor:
FHI 360
Collaborators:
Ministry of Health and Public Hygiene (Cote d'Ivoire) Programme National de Lutte contre les Maladies Tropicales Négligées à Chimiothérapie Préventive, Côte d'Ivoire